Central Trust CO Amgen Inc Transaction History

Central Trust CO

$3.97 Billion
Q1 2025

A detailed history of Central Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Central Trust CO holds 37,536 shares of AMGN stock, worth $10.5 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

37,536

Previous 38,831 3.33%

Holding current value

$10.5 Million

Previous $10.1 Million 15.55%

% of portfolio

0.29%

Previous 0.25%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	SELL	$258.59 - $327.36 $334,874 - $423,931	-1,295 Reduced 3.33%	37,536 $11.7 Million
Q4 2024 Jan 24, 2025	SELL	$258.78 - $328.31 $1.39 Million - $1.77 Million	-5,384 Reduced 12.18%	38,831 $10.1 Million
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $229,250 - $249,998	-741 Reduced 1.65%	44,215 $14.2 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $265,640 - $322,822	-1,011 Reduced 2.2%	44,956 $14 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $436,107 - $526,436	-1,622 Reduced 3.41%	45,967 $13.1 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $139,100 - $156,922	-544 Reduced 1.13%	47,589 $13.7 Million
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $753,905 - $935,994	-3,448 Reduced 6.68%	48,133 $12.9 Million
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $19,284 - $22,803	90 Added 0.17%	51,581 $11.5 Million
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $8,805 - $10,732	39 Added 0.08%	51,491 $12.4 Million
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $8,474 - $10,767	-37 Reduced 0.07%	51,452 $0
Q3 2022 Nov 17, 2022	SELL	$224.46 - $253.15 $36,811 - $41,516	-164 Reduced 0.32%	51,489 $11.6 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $6,690 - $7,445	29 Added 0.06%	51,653 $12.6 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $80,252 - $88,780	366 Added 0.71%	51,624 $12.5 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $223,541 - $255,822	1,124 Added 2.24%	51,258 $11.5 Million
Q3 2021 Oct 19, 2021	SELL	$212.27 - $248.7 $807,687 - $946,303	-3,805 Reduced 7.05%	50,134 $10.7 Million
Q2 2021 Jul 23, 2021	SELL	$233.58 - $259.14 $1.31 Million - $1.46 Million	-5,627 Reduced 9.45%	53,939 $13.1 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $408,980 - $476,599	1,843 Added 3.19%	59,566 $14.8 Million
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $470,842 - $560,689	2,176 Added 3.92%	57,723 $13.3 Million
Q3 2020 Oct 22, 2020	BUY	$234.65 - $260.95 $354,790 - $394,556	1,512 Added 2.8%	55,547 $14.1 Million
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $316,496 - $388,384	1,600 Added 3.05%	54,035 $12.7 Million
Q1 2020 Apr 17, 2020	SELL	$182.24 - $241.7 $94,764 - $125,684	-520 Reduced 0.98%	52,435 $10.6 Million
Q4 2019 Jan 21, 2020	SELL	$189.21 - $243.2 $94,415 - $121,356	-499 Reduced 0.93%	52,955 $12.8 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $456,864 - $547,418	-2,624 Reduced 4.68%	53,454 $10.3 Million
Q2 2019 Jul 12, 2019	SELL	$166.7 - $195.41 $1.02 Million - $1.2 Million	-6,118 Reduced 9.84%	56,078 $0
Q1 2019 Apr 26, 2019	SELL	$180.87 - $203.88 $1.15 Million - $1.29 Million	-6,343 Reduced 9.25%	62,196 $0
Q4 2018 Jan 08, 2019	BUY	$178.4 - $208.25 $353,945 - $413,168	1,984 Added 2.98%	68,539 $13.3 Million
Q3 2018 Oct 04, 2018	SELL	$185.29 - $208.89 $97,091 - $109,458	-524 Reduced 0.78%	66,555 $0
Q2 2018 Jul 09, 2018	SELL	$166.05 - $186.51 $143,799 - $161,517	-866 Reduced 1.27%	67,079 $0
Q1 2018 Apr 04, 2018	SELL	$169.43 - $198.0 $123,006 - $143,748	-726 Reduced 1.06%	67,945 $0
Q4 2017 Jan 23, 2018	SELL	$168.79 - $188.59 $180,774 - $201,979	-1,071 Reduced 1.54%	68,671 $0
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $11.7 Million - $13.3 Million	69,742	69,742 $0

Others Institutions Holding AMGN

# of Institutions

3,306

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account